Finally, the combined immunologic and neurologic effects of bioactive Trp catabolites emphasizes the key roles of IDO and the Kyn pathway as drivers or regulators of many chronic conditions and common comorbidities, including pain depression and fatigue. This evidence concerns the gene IDO1 and depressive symptom measurement.